These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 113305)

  • 21. [Antithrombin III: the correlation structure-function in healthy people and in cirrhotic patients (author's transl)].
    Vicente JM; Díaz Cremades JM; Borrell M; Felez J; Gimferrer E; Pujol N; Domingo A; Rutllant ML
    Sangre (Barc); 1978; 23(5):544-53. PubMed ID: 368998
    [No Abstract]   [Full Text] [Related]  

  • 22. Heparin: biochemistry, therapy, and laboratory monitoring.
    Triplett DA
    Ther Drug Monit; 1979; 1(2):173-97. PubMed ID: 555571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Assays of antithrombin III by bioimmunologic methods (author's transl)].
    Marchesi NR; Albina RM; Castuma JC; Paolicchi DR; Bergna LJ
    Sangre (Barc); 1979; 24(2):199-204. PubMed ID: 380024
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antithrombin III and its role in normal and pathological hemostasis].
    Bŭchvarova V; Doĭchinov A; Angelova N
    Vutr Boles; 1981; 20(6):34-8. PubMed ID: 7039127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of two-stage antithrombin III assay using new chromogenic peptide substrates (author's transl)].
    Asai K; Takagi A; Otsubo M
    Rinsho Byori; 1980 Jan; 28(1):76-80. PubMed ID: 7373879
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparison between anticoagulant activity and antigenicity of plasma antithrombin III in healthy subjects and patients with disseminated intravascular coagulation (DIC) (author's transl)].
    Matsuda T; Ogawara M; Miura R; Seki T; Yokouchi M; Murakami M; Fujisawa M; Nakanishi K; Nakamura S
    Rinsho Ketsueki; 1980 Mar; 21(3):341-6. PubMed ID: 6157843
    [No Abstract]   [Full Text] [Related]  

  • 27. Some properties of human progressive antithrombin.
    Pálos LA; Blaskó G; Machovich R
    Acta Physiol Acad Sci Hung; 1977; 49(2):95-101. PubMed ID: 754468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Thrombosis of the portal and superior mesenteric veins in a patient with a congenital and familial deficiency in antithrombin III (author's transl)].
    Juillet Y; Vayssairat M; Fiessinger JN; Aiach M; Housset E
    Ann Med Interne (Paris); 1979; 130(2):53-7. PubMed ID: 434715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The physiological inhibitors of blood coagulation. 1. Antithrombin III (AT III)].
    Kase F; Pospísil J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(3):337-49. PubMed ID: 6194066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antithrombin III in liver disorders.
    Sundar S; Mall RK; Dube B; Singh VP
    J Assoc Physicians India; 1991 Jul; 39(7):522-4. PubMed ID: 1800493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antithrombin III. Structure, pathophysiology, determination and therapeutic importance].
    Hrkal Z; Vorlová Z
    Cas Lek Cesk; 1992 Dec; 131(24-25):749-53. PubMed ID: 1288878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antithrombin III. Antithrombin].
    Sas G
    Orv Hetil; 1982 Apr; 123(16):959-62. PubMed ID: 7078951
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical evaluations of antithrombin III and alpha 2-plasmin inhibitor assay method with chromogenic substrates (S-2238, S-2251 (author's transl)].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1981 Feb; 29(2):179-82. PubMed ID: 6453246
    [No Abstract]   [Full Text] [Related]  

  • 34. [10-Thiaänthracenes. III. Syntheses of 10-phenyl-10-thiaänthracenes having a basic group at 1 position (author's transl)].
    Hori M; Kataoka T; Shimizu H; Yoshimuna S
    Yakugaku Zasshi; 1975 Feb; 95(2):138-46. PubMed ID: 1170292
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antithrombin II. Immunological and biological levels in hepatic cirrhosis and in disseminated intravascular coagulation (author's transl)].
    Barrantes A; Fonseca JE
    Sangre (Barc); 1979; 24(6):1043-7. PubMed ID: 538557
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antithrombin III deficiency: when substitute, when heparin? Thrombosis ABC, 3: The role of antithrombin III].
    Stiefelhagen P
    MMW Fortschr Med; 1999 Sep; 141(37):41. PubMed ID: 10897973
    [No Abstract]   [Full Text] [Related]  

  • 37. [beta-Arylaminoacrolein derivatives. III. Synthesis of malonaldehyde dianil derivatives and their reaction (author's transl)].
    Tamura S; Adachi Y; Takeda S
    Yakugaku Zasshi; 1976 Mar; 96(3):388-92. PubMed ID: 986457
    [No Abstract]   [Full Text] [Related]  

  • 38. Antithrombin III: introduction.
    Menache D
    Semin Hematol; 1991 Jan; 28(1):1-2. PubMed ID: 2017685
    [No Abstract]   [Full Text] [Related]  

  • 39. [Assay of antithrombin III and soluble fibrin complexes in the study of blood thrombophilia (author's transl)].
    Colombo LA; Corberi OM; Finzi M; Rossi G
    Chir Ital; 1979 Aug; 31(4):650-61. PubMed ID: 553732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Selenazoles. III. The reaction of isonicotinic acid 4-R-selenosemicarbazides with chloracetone (author's transl)].
    Biliński S; Chmielewski J
    Ann Univ Mariae Curie Sklodowska Med; 1977; 32():231-9. PubMed ID: 614805
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.